Last reviewed · How we verify
Physician's choice treatments group — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Physician's choice treatments group (Physician's choice treatments group) — Yeon Hee Park.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Physician's choice treatments group TARGET | Physician's choice treatments group | Yeon Hee Park | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Physician's choice treatments group CI watch — RSS
- Physician's choice treatments group CI watch — Atom
- Physician's choice treatments group CI watch — JSON
- Physician's choice treatments group alone — RSS
Cite this brief
Drug Landscape (2026). Physician's choice treatments group — Competitive Intelligence Brief. https://druglandscape.com/ci/physician-s-choice-treatments-group. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab